2025. Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions. Current Pharmaceutical Research. 1, 3 (Oct. 2025), 308–322. DOI:https://doi.org/10.63785/cpr.2025.1.3.308322.